Indeed, Skp2 has been found to be frequently overexpressed in a variety of human cancers including lymphomas [12], prostate cancer [13], melanoma [14], nasopharyngeal carcinoma [15], pancreatic cancer [16], and breast carcinomas [17, 18]. Here, SKP2 is linked to cancer.